IAPP / Amylin Antibody (N-Terminus)
Rabbit Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| IHC-P |
---|---|
Primary Accession | P10997 |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Calculated MW | 10kDa |
Dilution | IHC-P (10 µg/ml) |
Gene ID | 3375 |
---|---|
Other Names | Islet amyloid polypeptide, Amylin, Diabetes-associated peptide, DAP, Insulinoma amyloid peptide, IAPP |
Reconstitution & Storage | +4°C or -20°C, Avoid repeated freezing and thawing. |
Precautions | IAPP / Amylin Antibody (N-Terminus) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | IAPP |
---|---|
Function | Selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle, while not affecting adipocyte glucose metabolism. |
Cellular Location | Secreted. |
Volume | 250 µl |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle, while not affecting adipocyte glucose metabolism.
References
Mosselman S.,et al.FEBS Lett. 247:154-158(1989).
Nishi M.,et al.Mol. Endocrinol. 3:1775-1781(1989).
Sanke T.,et al.J. Biol. Chem. 263:17243-17246(1988).
Christmanson L.,et al.FEBS Lett. 267:160-166(1990).
van Mansfeld A.D.M.,et al.Biochim. Biophys. Acta 1087:235-240(1990).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.